All
U.S. Pharmaceuticals Quarterly Review : Drug Shortages, State Coverage of Anti-Obesity Medications, and the PBM Transparency Debate
The pharmaceutical sector in the United States grappled with an unprecedented drug shortage crisis in the first quarter of 2024, with 323 individual drug scarcities recorded, notably impacting medications like Ozempic. States like Connecticut and Indiana are implementing measures to mitigate these shortages, highlighting the urgent need for proactive solutions in managing pharmaceutical supply disruptions.